98-32617. Draft Guidelines for HIV Case Surveillance, Including Monitoring HIV Infection and Acquired Immunodeficiency Syndrome (AIDS)  

  • [Federal Register Volume 63, Number 237 (Thursday, December 10, 1998)]
    [Notices]
    [Page 68289]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 98-32617]
    
    
    =======================================================================
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Centers for Disease Control and Prevention
    
    
    Draft Guidelines for HIV Case Surveillance, Including Monitoring 
    HIV Infection and Acquired Immunodeficiency Syndrome (AIDS)
    
    AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
    Health and Human Services (HHS).
    
    ACTION: Notice and Request for Comments.
    
    -----------------------------------------------------------------------
    
    SUMMARY: This notice announces the availability for public comment of a 
    document entitled ``Draft Guidelines for HIV Case Surveillance, 
    Including Monitoring HIV Infection and Acquired Immunodeficiency 
    Syndrome (AIDS)''.
    
    DATES: Comments must be submitted in writing on or before January 11, 
    1999. Comments should be submitted to the Technical Information and 
    Communications Branch, Mailstop E-49, Division of HIV/AIDS Prevention, 
    National Center for HIV, STD, and TB Prevention, Centers for Disease 
    Control and Prevention (CDC), Atlanta, Georgia 30333; Fax: 404-639-
    2007; E-mail: hivmail@cdc.gov.
    
    FOR FURTHER INFORMATION CONTACT: Requests for copies of the Draft HIV 
    Case Surveillance Guidelines should be submitted to the CDC National 
    Prevention Information Network, P.O. Box 6003, Rockville, Maryland 
    20849-6003; telephone (800) 458-5231; or copies can be obtained from 
    the CDC website at http://www.cdc.gov/nchstp/hiv__aids/dhap.htm.
    
    SUPPLEMENTARY INFORMATION: From 1995 to 1996, the incidence of both 
    deaths and opportunistic infections (OIs) due to AIDS declined in the 
    United States for the first time in the history of the epidemic (6 
    percent for OIs; 23 percent for deaths) as reported in the September 
    19, 1997, Morbidity and Mortality Weekly Report (MMWR) (Volume 46, pp. 
    861-867). These declines reflect recent advances in treatment of HIV 
    infection and the provision of care and services that have slowed the 
    progression of AIDS for HIV-infected persons on therapy and the success 
    of HIV prevention and education efforts that have encouraged early 
    diagnosis and have helped to reduce the number of Americans becoming 
    infected with HIV.
        In response to these changes in HIV treatment practices and new 
    information needs of public health programs, CDC, the Council of State 
    and Territorial Epidemiologists (CSTE), and most other public health 
    and AIDS organizations have recommended that all States and territories 
    conduct HIV case surveillance in addition to AIDS surveillance. In this 
    manner, the AIDS/HIV epidemic can be tracked more accurately, and 
    appropriate information about HIV/AIDS can be made available to 
    policymakers. As of July 1998, a total of 32 States were conducting HIV 
    case surveillance using the same methods as surveillance for AIDS. 
    Because some States (many with large numbers of AIDS cases) do not 
    report HIV case numbers, interpretations of available HIV data are 
    difficult. To gain more reliable information about the prevalence, 
    incidence, and future directions of HIV infection and the impact on 
    specific populations such as racial and ethnic minorities and women, 
    CDC is proposing that the current surveillance system be expanded to 
    include HIV case reporting for all States and is publishing guidelines 
    that States can use to implement HIV surveillance.
    
        Dated: December 3, 1998.
    Jeffrey P. Koplan,
    Director, Centers for Disease Control and Prevention (CDC).
    [FR Doc. 98-32617 Filed 12-9-98; 8:45 am]
    BILLING CODE 4163-18-P
    
    
    

Document Information

Published:
12/10/1998
Department:
Centers for Disease Control and Prevention
Entry Type:
Notice
Action:
Notice and Request for Comments.
Document Number:
98-32617
Dates:
Comments must be submitted in writing on or before January 11, 1999. Comments should be submitted to the Technical Information and Communications Branch, Mailstop E-49, Division of HIV/AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia 30333; Fax: 404-639- 2007; E-mail: hivmail@cdc.gov.
Pages:
68289-68289 (1 pages)
PDF File:
98-32617.pdf